Table 2.
Clinical features of 33 tumor samples
| Characteristics | Total of patients | ALKBH2 Low expression (≤ median) |
ALKBH2 High expression (> median) |
P value |
|---|---|---|---|---|
| Number | 33 | 17 | 16 | |
| Gender | 0.392 | |||
| Male | 21 | 12 | 9 | |
| Female | 12 | 5 | 7 | |
| Ages (years) | 0.325 | |||
| < 65 | 22 | 10 | 12 | |
| ≥ 65 | 11 | 7 | 4 | |
| Tumor site | 0.114 | |||
| Colon | 21 | 13 | 8 | |
| Rectum | 12 | 4 | 8 | |
| Tumor size(cm) | 0.387 | |||
| < 5 | 17 | 10 | 7 | |
| ≥ 5 | 16 | 7 | 9 | |
| Pathological T category | 0.009* | |||
| T1-T2 | 20 | 13 | 5 | |
| T3-T4 | 13 | 4 | 11 | |
| Lymph node metastasis | 0.026* | |||
| N0 | 26 | 16 | 10 | |
| N1-N2 | 7 | 1 | 6 | |
| Distant metastasis | 0.028* | |||
| M0 | 30 | 17 | 12 | |
| M1 | 3 | 0 | 4 | |
| TNM stage | 0.021* | |||
| I–II | 21 | 14 | 7 | |
| III–IV | 12 | 3 | 9 | |
| Differentiation | 0.353 | |||
| Well/moderate | 20 | 9 | 11 | |
| Poor | 13 | 8 | 5 |
*p < 0.05